NIVEDITHA MEGHADRI: Open Payments
NPI 1063501872 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 28 payments from 7 companies in 2025. Trend: 2023 $723 · 2024 $626 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $203 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, COBENFY, TRINTELLIX, AUSTEDO XR, VRAYLAR, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
